Disclosure 0001302443-26-000012-1

SEC FORM 4

$339,576.30

Theravance Biopharma, Inc. (TBPH)

Disposition (code F) of 20,034 shares at $16.95 per share.

Reporting Person Winningham Rick E · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code F

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001302443-26-000012 · filed 2026-08-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Theravance Biopharma, Inc. (TBPH)." Disclosed 2026-08-24. https://desqlong.com/cards/0001302443-26-000012-1 (retrieved 2026-09-26).